chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: Like a light case of the flue; Joint pain; Headache; Fatigue, stayed in bed; Fever of 101.3 °F; Muscle ache; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed) and PYREXIA (Fever of 101.3 °F) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included RIVAROXABAN (XARELTO), GABAPENTIN, ATENOLOL, TRAMADOL and LINACLOTIDE (LINZESS) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed), PYREXIA (Fever of 101.3 °F) and MYALGIA (Muscle ache). On 06-Mar-2021, INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed), PYREXIA (Fever of 101.3 °F) and MYALGIA (Muscle ache) had resolved.            Treatment medication included Tylenol and Advil.  Action taken with mRNA-1273 in response to the event was Not Applicable   This case was linked to MOD-2021-218872 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Like a light case of the flue; Joint pain; Headache; Fatigue, stayed in bed; Fever of 101.3 °F; Muscle ache; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed) and PYREXIA (Fever of 101.3 °F) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included RIVAROXABAN (XARELTO), GABAPENTIN, ATENOLOL, TRAMADOL and LINACLOTIDE (LINZESS) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed), PYREXIA (Fever of 101.3 °F) and MYALGIA (Muscle ache). On 06-Mar-2021, INFLUENZA LIKE ILLNESS (Like a light case of the flue), ARTHRALGIA (Joint pain), HEADACHE (Headache), FATIGUE (Fatigue, stayed in bed), PYREXIA (Fever of 101.3 °F) and MYALGIA (Muscle ache) had resolved.            Treatment medication included Tylenol and Advil.  Action taken with mRNA-1273 in response to the event was Not Applicable   This case was linked to MOD-2021-218872 (Patient Link).
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Developed pain in his left shoulder / later the right as well; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Developed pain in his left shoulder / later the right as well) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Joint replacement.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ARTHRALGIA (Developed pain in his left shoulder / later the right as well). At the time of the report, ARTHRALGIA (Developed pain in his left shoulder / later the right as well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small patch on the leg/small patch became a rash and spread to stomach, lower back, upper legs, Chest and under arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Small patch on the leg/small patch became a rash and spread to stomach, lower back, upper legs, Chest and under arms) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Jan-2021, the patient experienced RASH (Small patch on the leg/small patch became a rash and spread to stomach, lower back, upper legs, Chest and under arms). At the time of the report, RASH (Small patch on the leg/small patch became a rash and spread to stomach, lower back, upper legs, Chest and under arms) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Vaccination site rash
Clinical narrative: slight rash; Headache on and off; Throwing up; Chills; Fever; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (slight rash), HEADACHE (Headache on and off), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body Aches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history is provided and concomitant drugs are provided.  Concomitant products included ATORVASTATIN, HYDROCHLOROTHIAZIDE, CLOPIDOGREL, METFORMIN, PROPRANOLOL (PROPANOLOL [PROPRANOLOL]), LISINOPRIL, PANTOPRAZOLE, ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID, MAGNESIUM, PYRIDOXINE HYDROCHLORIDE (MAGNESIUM COMPLEX [ASCORBIC ACID;MAGNESIUM;PYRIDOXINE HYDROCHLORIDE]) and BIOTIN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body Aches). On 08-Feb-2021, the patient experienced VOMITING (Throwing up). On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (slight rash) and HEADACHE (Headache on and off). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (slight rash), HEADACHE (Headache on and off), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body Aches) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: slight rash; Headache on and off; Throwing up; Chills; Fever; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (slight rash), HEADACHE (Headache on and off), CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body Aches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history is provided and concomitant drugs are provided.  Concomitant products included ATORVASTATIN, HYDROCHLOROTHIAZIDE, CLOPIDOGREL, METFORMIN, PROPRANOLOL (PROPANOLOL [PROPRANOLOL]), LISINOPRIL, PANTOPRAZOLE, ACETYLSALICYLIC ACID (BABY ASPIRIN), ASCORBIC ACID, MAGNESIUM, PYRIDOXINE HYDROCHLORIDE (MAGNESIUM COMPLEX [ASCORBIC ACID;MAGNESIUM;PYRIDOXINE HYDROCHLORIDE]) and BIOTIN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body Aches). On 08-Feb-2021, the patient experienced VOMITING (Throwing up). On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (slight rash) and HEADACHE (Headache on and off). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (slight rash), HEADACHE (Headache on and off), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body Aches) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Swollen tongue, Throat tightness, Vaccination site pain
Clinical narrative: Light headed/Dizzy; Throate tight; sore arm at the injection site; tired; swollen tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Light headed/Dizzy), SWOLLEN TONGUE (swollen tongue), THROAT TIGHTNESS (Throate tight), VACCINATION SITE PAIN (sore arm at the injection site) and FATIGUE (tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Burning mouth (Burning mouth possibly from Actonel medication) from 15-Feb-2021 to 18-Mar-2021 and Cushing's disease (had Pituitary tumor surgery). Concurrent medical conditions included Drug allergy (Sulfonamide, Amoxicillin, Keflex, Levofloxacin, Cipro, Diflucan, Medroxyprogesterone Acetate, Drospirinone, Norenthindrone Acetate, Evista, Bactrim, Latanoprost Eye Drops, Travatan Z Eye Drops), Hypertension, Osteoporosis, GERD and Restless legs. Concomitant products included FAMOTIDINE for GERD, LOSARTAN for Hypertension, VITAMIN D3 for Osteoporosis, PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE [PRAMIPEXOLE DIHYDROCHLORIDE]) for Restless legs.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced SWOLLEN TONGUE (swollen tongue). On an unknown date, the patient experienced DIZZINESS (Light headed/Dizzy), THROAT TIGHTNESS (Throate tight), VACCINATION SITE PAIN (sore arm at the injection site) and FATIGUE (tired). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form; LORATADINE (CLARITINE) at a dose of UNK dosage form; FAMOTIDINE (PEPCID [FAMOTIDINE]) at a dose of UNK dosage form and PREDNISOLONE (PREDNERSONE) from 07-Mar-2021 to 24-Mar-2021 for Swelling, at a dose of UNK dosage form. On 24-Mar-2021, SWOLLEN TONGUE (swollen tongue) had resolved. At the time of the report, DIZZINESS (Light headed/Dizzy), THROAT TIGHTNESS (Throate tight), VACCINATION SITE PAIN (sore arm at the injection site) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Patient demographics added(Height, Weight), Historical conditions added, Treatment medications added, Outcome of the event added. Batch number of suspect product added.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Tongue discolouration
Clinical narrative: Pink tongue; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and TONGUE DISCOLOURATION (Pink tongue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced TONGUE DISCOLOURATION (Pink tongue). At the time of the report, DIARRHOEA (diarrhea) and TONGUE DISCOLOURATION (Pink tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and TONGUE DISCOLOURATION (Pink tongue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced TONGUE DISCOLOURATION (Pink tongue). At the time of the report, DIARRHOEA (diarrhea) and TONGUE DISCOLOURATION (Pink tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Sex: M
Vaccine: COVID19
Symptoms: Eye irritation, Eye pain, Fatigue, Lacrimation increased, Ocular hyperaemia
Clinical narrative: eye was red and irritated, thought it was pink eye; extremely tired; Pricking pain in left eye similar to a pen poke; burning sensation when eye was closed; Watering from the eye when opening it; slept most of the day; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day) and OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day) and FATIGUE (extremely tired). On 06-Mar-2021, the patient experienced OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye). At the time of the report, EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day), OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye) and FATIGUE (extremely tired) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: eye was red and irritated, thought it was pink eye; extremely tired; Pricking pain in left eye similar to a pen poke; burning sensation when eye was closed; Watering from the eye when opening it; slept most of the day; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day) and OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day) and FATIGUE (extremely tired). On 06-Mar-2021, the patient experienced OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye). At the time of the report, EYE PAIN (Pricking pain in left eye similar to a pen poke), EYE IRRITATION (burning sensation when eye was closed), LACRIMATION INCREASED (Watering from the eye when opening it), SOMNOLENCE (slept most of the day), OCULAR HYPERAEMIA (eye was red and irritated, thought it was pink eye) and FATIGUE (extremely tired) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable No concomitant medications were reported No treatment drugs were reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pain in extremity, Swelling of eyelid
Clinical narrative: eyelid kind of swollen; flu like symptoms; achy; soreness of the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of the arm), SWELLING OF EYELID (eyelid kind of swollen), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness of the arm). On 08-Mar-2021, the patient experienced SWELLING OF EYELID (eyelid kind of swollen), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy). At the time of the report, PAIN IN EXTREMITY (soreness of the arm), SWELLING OF EYELID (eyelid kind of swollen), INFLUENZA LIKE ILLNESS (flu like symptoms) and PAIN (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Myalgia
Clinical narrative: lethargy; myalgia; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargy), MYALGIA (myalgia) and FATIGUE (tiredness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced LETHARGY (lethargy), MYALGIA (myalgia) and FATIGUE (tiredness). On 07-Feb-2021, LETHARGY (lethargy), MYALGIA (myalgia) and FATIGUE (tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported.   This case was linked to MOD-2021-043740 (Patient Link).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Sore arm; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache) and FATIGUE (Fatigue) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE PAIN (Sore arm), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported.  No treatment medications was provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-041797 (E2B Linked Report).; Sender's Comments:  MOD-2021-041797:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer, Burning sensation, Headache, Induration
Clinical narrative: canker sore on his nose; burns; hard to touch; headache; A spontaneous report was received from a consumer concerning a 67-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a canker sore on his nose/aphthous ulcer, it burns really bad/burning sensation, headache/headache,  and hard to touch/induration.  The patient's medical history included staphylococcal infection and canker sores. No relevant concomitant medications were provided.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Batch/lot number:not provided) for prophylaxis of COVID-19 infection.   On an unknown date, approximately 2 weeks after the vaccination, the patient developed a canker sore on his nose, it burns really bad, and gives him a headache, it was hard to touch.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, canker sore on his nose, burning, headache, and hard to touch, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. The canker sore is probably related to the patient's medical history of canker sores.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area; This spontaneous case was reported by an other health care professional and describes the occurrence of CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area). At the time of the report, CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area). At the time of the report, CONTUSION (linear bruising in groups of four that appeared on her left upper thigh and on the right side around the wrist/ palm area) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Medications for Heart Problems. Treatment Medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up was received on 03-MAY-2021 contains No New Information. On 22-Jun-2021: Follow-up information received on 22-JUN-2021 contains second dose details and Concomitant Medication.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dry mouth, Growth of eyelashes, Hyperhidrosis, Hypotension
Clinical narrative: could not sleep; tingling sensation in her eyelashes and they grew in size; tingling sensation in her eyelashes and they grew in size; soreness in the injection arm; dry mouth; Nausea; Soreness; feeling dopey; blurry vision; Sweats; fast heartbeat; low blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat) and HYPOTENSION (low blood pressure) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included VITAMINS NOS (DAILY VITAMINS), ASPIRIN [ACETYLSALICYLIC ACID], AMLODIPINE and ATENOLOL for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), HYPOTENSION (low blood pressure), PAIN (Soreness) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced DRY MOUTH (dry mouth). On an unknown date, the patient experienced INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm). On 06-Mar-2021, SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), PAIN (Soreness) and NAUSEA (Nausea) had resolved. At the time of the report, HYPOTENSION (low blood pressure), DRY MOUTH (dry mouth), INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: decreased (Low) Blood pressure dropped..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   This case was linked to MOD-2021-254142.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received contains No New information On 12-Jul-2021: Follow up received contains Updated Reporter contact detail,Added lab data and concomitant medications, Added New Events(Insomnia, Paresthesia, Growth of eye lashes, Vaccination site pain).Updated Outcome of all the events to Recovered.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Pain, Paraesthesia, Sluggishness
Clinical narrative: could not sleep; tingling sensation in her eyelashes and they grew in size; tingling sensation in her eyelashes and they grew in size; soreness in the injection arm; dry mouth; Nausea; Soreness; feeling dopey; blurry vision; Sweats; fast heartbeat; low blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat) and HYPOTENSION (low blood pressure) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included VITAMINS NOS (DAILY VITAMINS), ASPIRIN [ACETYLSALICYLIC ACID], AMLODIPINE and ATENOLOL for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), HYPOTENSION (low blood pressure), PAIN (Soreness) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced DRY MOUTH (dry mouth). On an unknown date, the patient experienced INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm). On 06-Mar-2021, SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), PAIN (Soreness) and NAUSEA (Nausea) had resolved. At the time of the report, HYPOTENSION (low blood pressure), DRY MOUTH (dry mouth), INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: decreased (Low) Blood pressure dropped..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   This case was linked to MOD-2021-254142.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received contains No New information On 12-Jul-2021: Follow up received contains Updated Reporter contact detail,Added lab data and concomitant medications, Added New Events(Insomnia, Paresthesia, Growth of eye lashes, Vaccination site pain).Updated Outcome of all the events to Recovered.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vaccination site pain, Vision blurred
Clinical narrative: could not sleep; tingling sensation in her eyelashes and they grew in size; tingling sensation in her eyelashes and they grew in size; soreness in the injection arm; dry mouth; Nausea; Soreness; feeling dopey; blurry vision; Sweats; fast heartbeat; low blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat) and HYPOTENSION (low blood pressure) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included VITAMINS NOS (DAILY VITAMINS), ASPIRIN [ACETYLSALICYLIC ACID], AMLODIPINE and ATENOLOL for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), HYPOTENSION (low blood pressure), PAIN (Soreness) and NAUSEA (Nausea). On 06-Mar-2021, the patient experienced DRY MOUTH (dry mouth). On an unknown date, the patient experienced INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm). On 06-Mar-2021, SLUGGISHNESS (feeling dopey), VISION BLURRED (blurry vision), HYPERHIDROSIS (Sweats), TACHYCARDIA (fast heartbeat), PAIN (Soreness) and NAUSEA (Nausea) had resolved. At the time of the report, HYPOTENSION (low blood pressure), DRY MOUTH (dry mouth), INSOMNIA (could not sleep), PARAESTHESIA (tingling sensation in her eyelashes and they grew in size), GROWTH OF EYELASHES (tingling sensation in her eyelashes and they grew in size) and VACCINATION SITE PAIN (soreness in the injection arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: decreased (Low) Blood pressure dropped..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   This case was linked to MOD-2021-254142.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received contains No New information On 12-Jul-2021: Follow up received contains Updated Reporter contact detail,Added lab data and concomitant medications, Added New Events(Insomnia, Paresthesia, Growth of eye lashes, Vaccination site pain).Updated Outcome of all the events to Recovered.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nasal congestion
Clinical narrative: nasal congestion; sinus congestion; fatigue/ Debilitating fatigue/ residual fatigue; chills/ mild chills; Body aches after first dose; Minor headaches/ mild headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills) and MYALGIA (Body aches after first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Basal cell carcinoma face, Thyroid disorder NOS, Allergic reaction to analgesics, Allergic reaction to antibiotics, Drug allergy and Allergic rhinitis due to pollen. Concomitant products included PROGESTERONE and ESTRADIOL for Hormone replacement therapy, CHLORTHALIDONE for Hypercalciuria.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills), MYALGIA (Body aches after first dose) and HEADACHE (Minor headaches/ mild headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills), MYALGIA (Body aches after first dose) and HEADACHE (Minor headaches/ mild headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory details were  provided.  Concomitant medicine-thyroid supplement, gabapentin, Imiquimod cream   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Follow up 1 On 06-Jun-2021: FU1 additional inforamtion
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus congestion
Clinical narrative: nasal congestion; sinus congestion; fatigue/ Debilitating fatigue/ residual fatigue; chills/ mild chills; Body aches after first dose; Minor headaches/ mild headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills) and MYALGIA (Body aches after first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Basal cell carcinoma face, Thyroid disorder NOS, Allergic reaction to analgesics, Allergic reaction to antibiotics, Drug allergy and Allergic rhinitis due to pollen. Concomitant products included PROGESTERONE and ESTRADIOL for Hormone replacement therapy, CHLORTHALIDONE for Hypercalciuria.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills), MYALGIA (Body aches after first dose) and HEADACHE (Minor headaches/ mild headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (nasal congestion), SINUS CONGESTION (sinus congestion), FATIGUE (fatigue/ Debilitating fatigue/ residual fatigue), CHILLS (chills/ mild chills), MYALGIA (Body aches after first dose) and HEADACHE (Minor headaches/ mild headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory details were  provided.  Concomitant medicine-thyroid supplement, gabapentin, Imiquimod cream   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Follow up 1 On 06-Jun-2021: FU1 additional inforamtion
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Tongue erythema
Clinical narrative: pink tongue (possible); spontaneous diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (spontaneous diarrhea) and TONGUE ERYTHEMA (pink tongue (possible)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DIARRHOEA (spontaneous diarrhea). On an unknown date, the patient experienced TONGUE ERYTHEMA (pink tongue (possible)). At the time of the report, DIARRHOEA (spontaneous diarrhea) and TONGUE ERYTHEMA (pink tongue (possible)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling well) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Not feeling well). On 08-Mar-2021, FEELING ABNORMAL (Not feeling well) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter . Treatment Medications  were not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness). At the time of the report, VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Flu like symptoms, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.            Concomitant product use were not reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Pulmonary pain
Clinical narrative: Lungs were hurting; The patient was coughing like was going to cough up a lung; Throat soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Lungs were hurting), COUGH (The patient was coughing like was going to cough up a lung) and OROPHARYNGEAL PAIN (Throat soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PULMONARY PAIN (Lungs were hurting), COUGH (The patient was coughing like was going to cough up a lung) and OROPHARYNGEAL PAIN (Throat soreness). On 07-Mar-2021, PULMONARY PAIN (Lungs were hurting), COUGH (The patient was coughing like was going to cough up a lung) and OROPHARYNGEAL PAIN (Throat soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075528 (Patient Link).